BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 22000355)

  • 1. Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006.
    Park BJ; Pappas PG; Wannemuehler KA; Alexander BD; Anaissie EJ; Andes DR; Baddley JW; Brown JM; Brumble LM; Freifeld AG; Hadley S; Herwaldt L; Ito JI; Kauffman CA; Lyon GM; Marr KA; Morrison VA; Papanicolaou G; Patterson TF; Perl TM; Schuster MG; Walker R; Wingard JR; Walsh TJ; Kontoyiannis DP
    Emerg Infect Dis; 2011 Oct; 17(10):1855-64. PubMed ID: 22000355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging fungal infections in solid organ transplant recipients.
    Shoham S
    Infect Dis Clin North Am; 2013 Jun; 27(2):305-16. PubMed ID: 23714342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mold Infections in Solid Organ Transplant Recipients.
    Lemonovich TL
    Infect Dis Clin North Am; 2018 Sep; 32(3):687-701. PubMed ID: 30146030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET).
    Kauffman CA; Freifeld AG; Andes DR; Baddley JW; Herwaldt L; Walker RC; Alexander BD; Anaissie EJ; Benedict K; Ito JI; Knapp KM; Lyon GM; Marr KA; Morrison VA; Park BJ; Patterson TF; Schuster MG; Chiller TM; Pappas PG
    Transpl Infect Dis; 2014 Apr; 16(2):213-24. PubMed ID: 24589027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.
    Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA
    Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of the 'Big Five' mold killers of humans: Aspergillus, Fusarium, Lomentospora, Scedosporium and Mucormycetes.
    Thornton CR
    Adv Appl Microbiol; 2020; 110():1-61. PubMed ID: 32386603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing epidemiology of systemic fungal infections.
    Richardson M; Lass-Flörl C
    Clin Microbiol Infect; 2008 May; 14 Suppl 4():5-24. PubMed ID: 18430126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of invasive mold infections in lung transplant recipients.
    Doligalski CT; Benedict K; Cleveland AA; Park B; Derado G; Pappas PG; Baddley JW; Zaas DW; Harris MT; Alexander BD
    Am J Transplant; 2014 Jun; 14(6):1328-33. PubMed ID: 24726020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).
    Pappas PG; Alexander BD; Andes DR; Hadley S; Kauffman CA; Freifeld A; Anaissie EJ; Brumble LM; Herwaldt L; Ito J; Kontoyiannis DP; Lyon GM; Marr KA; Morrison VA; Park BJ; Patterson TF; Perl TM; Oster RA; Schuster MG; Walker R; Walsh TJ; Wannemuehler KA; Chiller TM
    Clin Infect Dis; 2010 Apr; 50(8):1101-11. PubMed ID: 20218876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive fungal infections in lung transplant recipients not receiving routine systemic antifungal prophylaxis: 12-year experience at a university lung transplant center.
    Pinney MF; Rosenberg AF; Hampp C; Schain D; Akindipe O; Baz M
    Pharmacotherapy; 2011 Jun; 31(6):537-45. PubMed ID: 21923437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive mold infections in lung and heart-lung transplant recipients: Stanford University experience.
    Vazquez R; Vazquez-Guillamet MC; Suarez J; Mooney J; Montoya JG; Dhillon GS
    Transpl Infect Dis; 2015 Apr; 17(2):259-66. PubMed ID: 25648194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.
    Husain S; Alexander BD; Munoz P; Avery RK; Houston S; Pruett T; Jacobs R; Dominguez EA; Tollemar JG; Baumgarten K; Yu CM; Wagener MM; Linden P; Kusne S; Singh N
    Clin Infect Dis; 2003 Jul; 37(2):221-9. PubMed ID: 12856215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients.
    Bhatti Z; Shaukat A; Almyroudis NG; Segal BH
    Mycopathologia; 2006 Jul; 162(1):1-15. PubMed ID: 16830186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voriconazole in the treatment of invasive mold infections in transplant recipients.
    Fortún J; Martín-Dávila P; Sánchez MA; Pintado V; Alvarez ME; Sánchez-Sousa A; Moreno S
    Eur J Clin Microbiol Infect Dis; 2003 Jul; 22(7):408-13. PubMed ID: 12827536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET).
    McCarty TP; Baddley JW; Walsh TJ; Alexander BD; Kontoyiannis DP; Perl TM; Walker R; Patterson TF; Schuster MG; Lyon GM; Wingard JR; Andes DR; Park BJ; Brandt ME; Pappas PG;
    Med Mycol; 2015 Jun; 53(5):440-6. PubMed ID: 25908651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive fungal infections in renal transplant recipients: about 11 cases.
    Trabelsi H; Néji S; Sellami H; Yaich S; Cheikhrouhou F; Guidara R; Charffedine K; Makni F; Hachicha J; Ayadi A
    J Mycol Med; 2013 Dec; 23(4):255-60. PubMed ID: 24060353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breakthrough invasive fungal infections: Who is at risk?
    Jenks JD; Cornely OA; Chen SC; Thompson GR; Hoenigl M
    Mycoses; 2020 Oct; 63(10):1021-1032. PubMed ID: 32744334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive Fungal Infections After Kidney Transplantation: A Single-center Experience.
    Santos T; Aguiar B; Santos L; Romaozinho C; Tome R; Macario F; Alves R; Campos M; Mota A
    Transplant Proc; 2015 May; 47(4):971-5. PubMed ID: 26036497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
    Salavert M
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S149-53. PubMed ID: 19013340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusarium infection in hematopoietic stem cell transplant recipients.
    Nucci M; Marr KA; Queiroz-Telles F; Martins CA; Trabasso P; Costa S; Voltarelli JC; Colombo AL; Imhof A; Pasquini R; Maiolino A; Souza CA; Anaissie E
    Clin Infect Dis; 2004 May; 38(9):1237-42. PubMed ID: 15127334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.